Hims & Hers offers compounded semaglutide at a starting rate of $199 a month - a sliver of the price of Wegovy, which can cost up to $1,350 a month. Given that getting insurance to cover the likes of Wegovy and Ozempic can be a challenge, it's not hard to see why compounded alternatives could have staying power.
Mark Mikhael, CEO of Olympia Pharmaceuticals, estimated that 30% of the nation's semaglutide might be made at compounding facilities, though he acknowledged that no one is currently tracking this data.
As the demand for diabetes and weight loss drugs grows, compounded alternatives might continue thriving, driven primarily by their lower cost compared to branded options.
The future of Ozempic and Wegovy, at least in the short term, seems to be one of growth for both these drugs and their compounded alternatives, as the pricing remains a familiar issue.
Collection
[
|
...
]